New Insight Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Sell
145,941
-7,283
-5% -$194K 1.47% 21
2025
Q4
$3.82M Buy
153,224
+61
+0% +$1.54K 1.36% 19
2025
Q3
$3.9M Sell
153,163
-14,671
-9% -$362K 1.47% 21
2025
Q2
$4.07M Buy
167,834
+31,696
+23% +$739K 1.67% 17
2025
Q1
$3.45M Buy
+136,138
New +$3.56M 1.57% 19
2024
Q4
Sell
-7,297
Closed -$211K 96
2024
Q3
$211K Sell
7,297
-2,399
-25% -$70K 0.11% 87
2024
Q2
$271K Sell
9,696
-6,482
-40% -$178K 0.16% 64
2024
Q1
$449K Sell
16,178
-13,315
-45% -$369K 0.28% 46
2023
Q4
$849K Buy
+29,493
New +$892K 0.57% 36

Other funds holding PFE

New Insight Wealth Advisors's PFE Position: Q1 2026 in Review

New Insight Wealth Advisors reduced its Pfizer (PFE) stake by 4.8% in Q1 2026, selling an estimated $194K and leaving 145,941 shares worth $4.1M. The position accounts for 1.47% of the portfolio, ranked #21.

New Insight Wealth Advisors first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • New Insight Wealth Advisors held 145,941 shares of Pfizer worth $4.1M as of Q1 2026.
  • New Insight Wealth Advisors sold 7,283 Pfizer shares in Q1 2026, an estimated $194K.
  • Pfizer made up 1.47% of New Insight Wealth Advisors's portfolio in Q1 2026, its #21 holding.
  • New Insight Wealth Advisors first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on New Insight Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.